Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Series TitleSeries Title
-
Reading LevelReading Level
-
YearFrom:-To:
-
More FiltersMore FiltersContent TypeItem TypeIs Full-Text AvailableSubjectCountry Of PublicationPublisherSourceTarget AudienceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
211,283
result(s) for
"Heroin"
Sort by:
The life of the heroin user : typical beginnings, trajectories and outcomes
\"Heroin is a worldwide scourge and a seemingly intractable one. The Life of the Heroin User: Typical Beginnings, Trajectories and Outcomes is the first book to apply a biographical approach to the lifecycle of the heroin user from birth until death. Chapters address each stage of the user's life, including childhood, routes to use, the development of dependence, problems arising from addiction, death and options for treatment and prevention. Drawing on over two decades of experience in the field of opium research, Shane Darke examines major theoretical approaches to the development of opiate dependence and the efficacy of treatment options for opiate dependence. Key points are presented at the end of each chapter. The most detailed review available of what is likely to happen to the dependent heroin user, this is an important book for clinicians, researchers and students in the fields of drug and alcohol studies and public health\"-- Provided by publisher.
Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction
by
Guh, Daphne
,
Brissette, Suzanne
,
Anis, Aslam
in
Addictive behaviors
,
Administration, Oral
,
Adult
2009
In this 12-month randomized trial involving 251 long-term heroin users, injectable diacetylmorphine (the active ingredient in heroin) was more effective than oral methadone in achieving retention in treatment for addiction and in reducing illicit-drug use and other illegal activity. As compared with methadone, injectable diacetylmorphine was associated with more serious adverse events, including seizures and drug overdoses.
In long-term heroin users, injectable diacetylmorphine (the active ingredient in heroin) was more effective than oral methadone in achieving retention in treatment for addiction and in reducing illicit-drug use and other illegal activity.
Opioid dependence, most commonly manifested as heroin dependence, is a chronic relapsing condition
1
that is estimated to affect more than 1 million persons in North America.
2
,
3
The risks of opioid dependence include fatal overdoses, infections (including endocarditis, human immunodeficiency virus infection, and hepatitis C virus infection), social disintegration, violence, and crime. The associated burdens on communities include medical, public health, and criminal-justice costs as well as public disorder and crimes against property.
Methadone, the standard opioid-substitution treatment, has been shown to reduce major risks associated with untreated opioid dependence in patients who are willing to undergo and are successfully . . .
Journal Article
Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction
2013
Despite evidence of the effectiveness of injectable opioid treatment compared with oral methadone for chronic heroin addiction, the additional cost of injectable treatment is considerable, and cost-effectiveness uncertain.
To compare the cost-effectiveness of supervised injectable heroin and injectable methadone with optimised oral methadone for chronic refractory heroin addiction.
Multisite, open-label, randomised controlled trial. Outcomes were assessed in terms of quality-adjusted life-years (QALYs). Economic perspective included health, social services and criminal justice resources.
Intervention costs over 26 weeks were significantly higher for injectable heroin (mean £8995 v. £4674 injectable methadone and £2596 oral methadone; P<0.0001). Costs overall were highest for oral methadone (mean £15 805 v. £13 410 injectable methadone and £10 945 injectable heroin; P = n.s.) due to higher costs of criminal activity. In cost-effectiveness analysis, oral methadone was dominated by injectable heroin and injectable methadone (more expensive and less effective). At willingness to pay of £30 000 per QALY, there is a higher probability of injectable methadone being more cost-effective (80%) than injectable heroin.
Injectable opioid treatments are more cost-effective than optimised oral methadone for chronic refractory heroin addiction. The choice between supervised injectable heroin and injectable methadone is less clear. There is currently evidence to suggest superior effectiveness of injectable heroin but at a cost that policy makers may find unacceptable. Future research should consider the use of decision analytic techniques to model expected costs and benefits of the treatments over the longer term.
Journal Article
Happy mutant baby pills : a novel
Lloyd has a particular set of skills. He writes the small print for prescription drugs, marital aids, and incontinence products. The clients present him with a list of possible side effects. His job is \"to \"ecite and minimize\", sometimes by just saying them really fast and other times by finding the language that can render them acceptable. The results are ingenious. The methods diabolical. Lloyd has a habit too. He cops smack during coffee breaks at his new job writing copy for Christian Swingles, an online dating service for the faithful. He finds a precarious balance between hackwork and heroin until he encounters Nora, a mysterious and troubled young woman, a Sylvia Plath with tattoos and implants, who asks for his help. Lloyd falls swiftly in love, but Nora bestows her affections at a cost. Before Lloyd clears his head from the fog of romance, he finds himself complicit in Nora's grand scheme to horrify the world and exact revenge on those who poison the populace in order to sell them the cure.
The pastoral clinic
2010
The Pastoral Clinic takes us on a penetrating journey into an iconic Western landscape—northern New Mexico’s Española Valley, home to the highest rate of heroin addiction and fatal overdoses in the United States. In a luminous narrative, Angela Garcia chronicles the lives of several Hispano addicts, introducing us to the intimate, physical, and institutional dependencies in which they are entangled. We discover how history pervades this region that has endured centuries of material and cultural dispossession, and we come to see its heroin problem as a contemporary expression of these conditions, as well as a manifestation of the human desire to be released from them. Lyrically evoking the Española Valley and its residents through conversations, encounters, and recollections, The Pastoral Clinic is at once a devastating portrait of addiction, a rich ethnography of place, and an eloquent call for a new ethics of care.
Lord Fear : a memoir
\"Lucas Mann was only thirteen years old when his brother Josh - charismatic and ambitious, funny and sadistic, violent and vulnerable - died of a heroin overdose. Although his brief life is ultimately unknowable, Josh is both a presence and an absence in the author s life that will not remain unclaimed. As Josh s story is told in kaleidoscopic shards of memories assembled from interviews with his friends and family, as well as from the raw material of his journals, a revealing, startling portrait unfolds. At the same time, Mann pulls back to examine his own complicated feelings and motives for recovering memories of his brother s life, searching for a balance between the tension of inevitability and the what ifs that beg to be asked. Through his investigation, Mann also comes to redefine his own place in a family whose narrative is bisected by the tragic loss\"--Publisher's description.
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
by
Compton, Wilson M
,
Jones, Christopher M
,
Baldwin, Grant T
in
Adolescent
,
Adult
,
Age Distribution
2016
A large fraction of heroin users now report that they formerly used prescription opioids nonmedically, a finding that has led to restrictions on opioid prescribing. Nevertheless, only a small fraction of prescription-opioid users move on to heroin use.
The nonmedical use of prescription opioids is a major public health issue in the United States, both because of the overall high prevalence and because of marked increases in associated morbidity and mortality.
1
In 2014, a total of 10.3 million persons reported using prescription opioids nonmedically (i.e., using medications that were not prescribed for them or were taken only for the experience or feeling that they caused).
2
Emergency department visits involving misuse or abuse of prescription opioids increased 153% between 2004 and 2011, and admissions to substance-abuse treatment programs linked to prescription opioids more than quadrupled between 2002 and 2012. . . .
Journal Article
Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin
by
Vosburg, Suzanne K.
,
Sullivan, Maria A.
,
Comer, Sandra D.
in
Adult
,
Affect - drug effects
,
Antagonist drugs
2006
Naltrexone is an opioid antagonist that is currently approved as a treatment for opioid and alcohol dependence. Although it is highly effective in completely antagonizing the effects of opioids, medication noncompliance is a difficult obstacle to treatment. Therefore, a sustained-release form of naltrexone may improve treatment outcome.
The present study was designed to evaluate the time course, safety, and effectiveness of a depot formulation of naltrexone (Depotrex).
Five heroin-dependent individuals participated in an 8-week inpatient study. After a 1-week detoxification period, the effects of a range of heroin doses (0, 6.25, 12.5, and 25 mg, i.v.) were examined. Participants then received 384 mg naltrexone base. The effects of heroin were again evaluated for the next 6 weeks. One dose of heroin was tested per day and the entire dose range was tested each week. Doses were administered in non-systematic order. During a morning sample session, participants received a dose of heroin and $20 and subjective, performance, and physiological effects were measured both before and after drug administration. During an afternoon choice session, participants were given the opportunity to choose the sampled heroin dose and/or amount of money using a modified progressive ratio procedure.
Depot naltrexone antagonized both the reinforcing and subjective effects of heroin for 4-5 weeks. Subjective ratings of withdrawal were reduced after week 2 and throughout the remainder of the study. The effects of heroin on mean trough pupil diameter began to emerge by week 5. There were no clinically significant effects on respiratory or cardiovascular function.
The present results extend our previous findings by showing that the reinforcing effects of heroin were reduced for 4-5 weeks after administration of 384 mg depot naltrexone.
Journal Article